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MYOCARDIAL BRIDGE 
▪ occurs when one of the coronary arteries tunnels through 
the myocardium rather than resting on top of it 
▪ in this case a band of heart tissue sits on top or surrounds 
of the coronary arteries 
▪ as the heart squeezes to pump blood, the muscle exerts 
pressure across the bridge and constricts the artery 
▪ are generally expressed clinically in young adult men, in 
whom typical or atypical chest pain appears, induced by 
physical exercise and appearing at rest 
 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733018/ 
INTRODUCTION 1.12 
❏  is an anomaly characterized by a typical intramyocardial 
route of a segment of one of the major coronary arteries 
❏  it was recognized at autopsy by Reyman in 1737, and first 
described angiographically by Portmann and Iwig in 1960 
❏ this anomaly is more frequent than previously thought; 
its reported incidence varies from 1.5% to 16% when 
assessed by coronary angiography, but can reach much 
higher percentages (from 40% to 80%) if estimated in 
the course of an autopsy series 
❏ is generally confined to the mid left anterior descending 
artery; it is less frequently located in the circumflex 
artery, and is occasionally seen in the right coronary 
artery                                       https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733018/ 
INTRODUCTION 2.12 
❏ clinical complications include ischemia and acute 
coronary syndromes, coronary spasm, ventricular septal 
rupture, arrhythmias (including supraventricular 
tachycardia and ventricular tachycardia), exercise-
induced atrioventricular conduction blocks, transient 
ventricular dysfunction and sudden death . The 
prognosis of patients with myocardial bridges, therefore, 
is not as benign as it was believed to be in the past 
 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733018/ 
 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065198/ 
INTRODUCTION 3.12 
The pathophysiological mechanisms of clinical 
manifestations: 
➢ It has been demonstrated that the intima of the 
tunnelled artery is significantly thinner than that of the 
proximal segment of the artery 
➢ the expression of vasoactive agents (endothelin-1, 
endothelial nitric oxide synthase, angiotensin-
converting enzyme) and the extension of the 
atherosclerotic process are diminished in the myocardial 
bridge compared with the proximal and subsequent 
artery segments 
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733018/ 
 
INTRODUCTION 4.12 
The typical angiographic feature is systolic narrowing of 
an epicardial artery, which is often completely resolved 
during the diastolic phase of the cardiac cycle. 
 Because only 15% of coronary flow normally occurs 
during systole and because the myocardial bridge is a 
systolic angiographic event, it acquires clinical relevance 
only in particular conditions, such as tachycardia. 
Tachycardia can provoke an ischemic effect on the 
myocardial bridge by shortening the diastolic phase and 
increasing the importance of systolic blood flow 
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733018/ 
 
INTRODUCTION 5.12 
Intracoronary ultrasonography and Doppler studies 
➔ the typical ‘half-moon’ phenomenon (echolucent area surrounding the 
myocardial bridge) -  demonstrating that the extrinsic compression of a 
tunnelled artery is not only a systolic event, but it also persists during a 
significant portion of the diastolic phase 
➔ characterized by a marked increase in blood flow  speed  during the early 
diastolic phase, followed by a sharp deceleration and a subsequent ‘plateau’ 
phase 
➔ during the systolic phase of the cardiac cycle, because of the extrinsic 
compression of the tunnelled artery, anterograde flow is not produced or is 
very reduced, and retrograde flow at the proximal segment of the 
myocardial bridge is observed 
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733018/ 
  
INTRODUCTION 6.12 
The therapeutic approaches are:  
➢beta-blockers 
➢calcium channel blockers 
➢coronary stents 
➢minimally invasive coronary artery 
bypass grafting  
➢ surgical myotomy 
 
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733018/ 
 
INTRODUCTION 7.12 
INTRODUCTION 8.12 
Nitrates should generally be avoided because 
they increase the angiographic degree of 
systolic narrowing and can lead to a worsening 
of clinical conditions 
INTRODUCTION 9.12 
Beta-blockers - reduce the cardiac frequency 
and increase the diastolic time, with a decrease 
in cardiac contractility and compression of the 
tunnelled artery 
INTRODUCTION 10.12 
Stenting of the myocardial bridge has, until now, given 
discordant results.  
Some studies  demonstrate that stenting can abolish 
hemodynamic alterations and improve symptoms, although 
no studies demonstrate normalization of myocardial 
perfusion when a perfusion defect was present before 
stenting.  
Moreover, high inflation pressures may be required for 
optimal stent implantation, which presents a higher risk of 
coronary perforation  
INTRODUCTION 11.12 
Surgical treatment with a dissection of the myocardial 
fibres that surround the myocardial bridge should be limited 
to patients with symptoms that persist despite medical 
treatment. Good clinical results have been reported in a 
small series of these patients, although this type of 
procedure is extremely delicate due to the possible 
appearance of dangerous complications, including right and 
left ventricular perforation 
https://academic.oup.com/eurheartj/article/26/12/1159/524878 
Surgical unroofing of the intramural coronary with myotomy. 
(Courtesy of Dr Thoralf M. Sundt III, by permission of Dr Thoralf 
M. Sundt III.) 
INTRODUCTION 12.12 
PATIENT PROFILE 
▪ 41 years old 
▪  Male 
▪ Occupation: businessman 
▪ Date of admission - 21.02.18  
MAIN COMPLAINTS 
▪ Chest pain (onset, strong, pressing, 
periodical, lasting for 10 - 15 minutes, more 
often after physical activity) 
▪ Dyspnea (expiratory, attack-like, after 
emotional overstrain, hard physical exercise) 
▪ Palpitation (paroxismal) 
▪ Headache (occipital region, pressing 
character, slight intensity 
▪ Heartburn (periodically) 
 
ANAMNESIS MORBI 
▪ Listed complaints were over 10 years 
▪ Arterial hypertension more than 10 years 
(adapted to 140-150/90 mm Hg) Patient took 
enalapril + hydrochlorothiazide 10mg/12.5 mg 
once a day. 
▪ According to the patient, he complained of 
dyspnea after hard exercise and increase of 
blood pressure   
▪ February 2018 – worsening of the disease, with 
complaints of chest pain and dyspnea 
 
ANAMNESIS VITAE 
 
▪Infections, injuries, tuberculosis, sexually 
transmitted diseases were denied.   
▪Allergological history is not burdened. 
▪Denies smoking and alcohol abuse 
▪Hereditary ( Father - died of a stroke; mother  
has arterial hypertension) 
▪Likes spicy food and fried fish 
 
OBJECTIVE EXAMINATION 1.3 
▪ GENERAL CONDITION:  The general condition of the 
patient is satisfactory and there is no obvious physical 
disability or distress.  
▪ Weight: 81 kg, height: 174 cm, BMI - 26.8 kg/m 
(overweight ) 
▪ Skin and visible mucous:  membranes are clean, pale pink 
and acyanotic  
▪ Peripheral lymph nodes are not palpable 
▪ Thyroid gland is normal size, consistency, not soldered to 
surrounding tissues. Symptom of   
     swallowing is negative 
 
 
 
▪ Cardiovascular system: heart rate = 68 bpm, 
pulse= 68 bpm;  
On auscultation the apex beat is at the 5th 
intercostal half an inch to the left of the 
midclavicular line. 
BP sin: 160/90 mmHg, BP dextra: 165/94 mmHg 
OBJECTIVE EXAMINATION 2.3 
▪ Respiratory system : pulmonary percussion 
-resonant sound. Pulmonary auscultation 
-vesicular breathing (no adventitious sounds) 
▪ Abdomen and GI: is normal on palpation, no 
rebound tenderness, painless on palpation. 
The liver and spleen are painless on palpation 
▪ There is no pitting edema of the lower limbs 
▪ Pasternasky’s sign is negative 
OBJECTIVE EXAMINATION 3.3 
PRELIMINARY DIAGNOSIS 
▪ Unstable Angina 
▪ Arterial Hypertension, stage II 
RECOMMENDED EXAMS 
▪ Complete blood test 
▪ General urine test 
▪ ECG 
▪ EchoCG (Intracoronary ultrasonography and Doppler studies) 
▪ Coagulogram 
▪ TSH, T4, anti-thyroid gland antibodies (anti-TG Ab) 
▪ Biochemical panel 
▪ Coronary Angiography 
▪ Biomarkers: troponin and BNP levels 
▪ Renal function tests (creatinine) 
▪  Blood lipid spectrum 
 
ANGIOGRAPHY 
Conclusion: shows 40% narrowing of the Left anterior descending artery by an 
artheroscleroctic plaque, the myocardial bridge  with systolic  compression up to 70 % 
LIPID PROFILE 
RESULT  
mmol/L 
NORMAL 
mmol/L 
Cholesterol 4.45 <5.3 
VLDL 0.36 <1.0 
LDL 2.82 <3.5 
HDL 1.27 >2.9 
TG 0.80 <2.3 
Conclusion: All the lipids are within the normal ranges 
indicating a good response to treatment and a favourable 
prognosis 
BLOOD TEST 
RESULT 
 
NORMAL 
 
CREATININE 77 mcrmole/L 44 – 80 mcrmole/L 
GLUCOSE 5.38 mmol/L 3.9 – 6.4 mmol/L 
Conclusion: Blood glucose and creatine are 
within normal range indicating normal kidney 
function 
CBC 
Conclusion: Normal  
ECG 
Conclusion: Sinus rhythm. Signs of left   
ventricular hypertrophy 
           
THYROID FUNCTION TESTS 
 Conclusion: within normal range 
 
ECHOCARDIOGRAPHY 
Conclusion: EF - 61 % (N= 55-78 %). Based on the 
echocardiograph the patient had asymmetric hypertrophy of 
the interventricular septum and hypertrophy of the left 
ventricle (concentric hypertrophy) and tricuspid regurgitation 
of the 1 st stage. 
THERAPEUTIC STRATEGY FOR MYOCARDIAL 
BRIDGING 
 (adapted from Schwartz et al) 
Clinical 
Symptoms 
Signs of 
Ischemia 
Initial 
Treatment 
Strategy 
Secondary 
Treatment if 
No 
Improvement 
Type A Yes No Reassurance – 
Type B Yes Yes, by non-
invasive stress 
testing 
Beta-blockers Intracoronary 
hemodynamic 
evaluation→ 
surgery or 
stenting if 
abnormal 
Type C Yes Yes, by altered 
intracoronary 
hemodynamics 
Beta-blockers Surgery or 
stenting 
 RECOMMENDED TREATMENT 
 
 
▪ Coronary stenting of LCA 
▪ Nebilet (Beta – Blocker + NO) 5 mg daily 
▪ Noliprel ( ACE inhibitor + Thiazide) daily 
▪ Cardiomagnil ( Aspirin + MgOH) 75 mg daily 
▪ Plavix (clopidogrel bisulfate) 75mg 
▪ Omeprazole 40 mg daily 
 
FOLLOW-UP  
(3 month later) 
❖Coronary stenting of LCA was done. 
❖The patient takes medication 
regularly. 
❖Patient's condition is much 
better: 
no chest pain, no palpitation,  
exercise tolerance increased. 
 
CLINICAL DIAGNOSIS 
Myocardial bridge of LCA with 
systolic compression 70%. Coronary 
stenting of LCA.  
Essential Arterial Hypertension, second 
grade, Heart failure with preserved 
ejection fraction II FC, stage A 
 
 
OUR RECOMMENDATION 
▪ The patient should have adequate rest to 
prevent working the heart as he has unstable 
angina. 
▪ The patient should also avoid fatty and spicy 
foods as he has heartburn and was given 
omeprazole. 
 
PROGNOSIS 
▪ The patient was in good physical condition 
and most of the lab tests were within the 
reference ranges. 
▪ There was no infarction of the heart tissue.  
▪ The stenosis and the myocardial bridge was 
surgically treated 
▪ Overall the prognosis is favourable with his 
chances of survival being positive 
CONCLUSION 
▪ the patient diagnosed with unstable angina, 
myocardial bridge and hypertension appears 
to be healthy and satisfied with his treatment 
▪ considering the epidemiological prevalence 
of these conditions, clinical suspicion of a 
myocardial bridge should be considered in all 
cases of typical or atypical chest pain; 
particularly in young patients with a low 
probability of atherosclerosis (which is 
confirmed by our clinical case) there is a 
connection with it) who are free from 
traditional cardiovascular risk factors 
 
LINKS 
● https://www.ncbi.nlm.nih.gov/pmc/articles/PMC406519
8/ (myocardial bridge) 
● https://en.wikipedia.org/wiki/Myocardial_bridge 
(myocardial bridge) 
● https://en.wikipedia.org/wiki/Acute_coronary_syndrome 
(acute coronary syndrome) 
● https://www.pinterest.com/pin/17381148533120757/ 
(human heart) 
● http://ctisus.com/responsive/learning/features/illustrate
d-coronary/anomalous-anatomy-10 (myocardial bridge) 
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